Distinct differences in the responses of the human pancreatic β-cell line endoc-βh1 and human islets to proinflammatory cytokines

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 309, Issue 5, 2015, Pages R525-R534

  Oleson, Bryndon J ^a   McGraw, Jennifer A ^a   Broniowska, Katarzyna A ^a   Annamalai, Mani ^b   Chen, Jing ^b   Bushkofsky, Justin R ^c   Davis, Dawn B ^c,d   Corbett, John A ^a   Mathews, Clayton E ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Cytokine; Diabetes; Insulinoma; Islet; Nitric oxide

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; STAT1 PROTEIN; THAPSIGARGIN; TUMOR NECROSIS FACTOR; AUTACOID; CYTOKINE; IFNG PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; INSULIN; INTERLEUKIN 1BETA; NOS2 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BIOENERGY; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RESPONSE; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; INSULIN RELEASE; INSULINOMA CELL LINE; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CELL DEATH; COMPARATIVE STUDY; DRUG EFFECTS; ENERGY METABOLISM; INSULINOMA; METABOLISM; PANCREAS ISLET; PANCREAS TUMOR; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TIME FACTOR; TISSUE CULTURE TECHNIQUE; TUMOR CELL LINE;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYTOKINES; ENERGY METABOLISM; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION MEDIATORS; INSULIN; INSULIN-SECRETING CELLS; INSULINOMA; INTERFERON-GAMMA; INTERLEUKIN-1BETA; ISLETS OF LANGERHANS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PANCREATIC NEOPLASMS; PHENOTYPE; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84940639041     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00544.2014     Document Type: Article

References (65)

1. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA. IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest 102: 516–526, 1998
2. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130: 167–178, 1992
3. Bellmann K, Jaattela M, Wissing D, Burkart V, Kolb H. Heat shock protein hsp70 overexpression confers resistance against nitric oxide. FEBS Lett 391: 185–188, 1996
4. Burkart V, Liu H, Bellmann K, Wissing D, Jaattela M, Cavallo MG, Pozzilli P, Briviba K, Kolb H. Natural resistance of human beta cells toward nitric oxide is mediated by heat shock protein 70. J Biol Chem 275: 19521–19528, 2000
5. Chambers KT, Unverferth JA, Weber SM, Wek RC, Urano F, Corbett JA. The role of nitric oxide and the unfolded protein response in cytokine-induced beta-cell death. Diabetes 57: 124–132, 2008
6. Chen J, Gusdon AM, Piganelli J, Leiter EH, Mathews CE. mt-Nd2(a) modifies resistance against autoimmune type 1 diabetes in NOD mice at the level of the pancreatic beta-cell. Diabetes 60: 355–359, 2011
7. Chen J, Gusdon AM, Thayer TC, Mathews CE. Role of increased ROS dissipation in prevention of T1D. Ann NY Acad Sci 1150: 157–166, 2008
8. Chick WL, Warren S, Chute RN, Like AA, Lauris V, Kitchen KC. A transplantable insulinoma in the rat. Proc Natl Acad Sci USA 74: 628–632, 1977
9. Collier JJ, Fueger PT, Hohmeier HE, Newgard CB. Pro- and antiapoptotic proteins regulate apoptosis but do not protect against cytokinemediated cytotoxicity in rat islets and beta-cell lines. Diabetes 55: 1398–1406, 2006
10. Corbett JA, Kwon G, Marino MH, Rodi CP, Sullivan PM, Turk J, McDaniel ML. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Am J Physiol Cell Physiol 270: C1581–C1587, 1996
11. Corbett JA, Lancaster JR Jr, Sweetland MA, McDaniel ML. Interleukin- 1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion. J Biol Chem 266: 21351–21354, 1991
12. Corbett JA, McDaniel ML. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochem J 299: 719–724, 1994
13. Corbett JA, Sweetland MA, Wang JL, Lancaster JR Jr, McDaniel ML. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 90: 1731–1735, 1993
14. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR Jr, Williamson JR, McDaniel ML. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552–556, 1992
15. Corbett JA, Wang JL, Sweetland MA, Lancaster JR Jr, McDaniel ML. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest 90: 2384–2391, 1992
16. Cunningham JM, Green IC. Cytokines, nitric oxide and insulin secreting cells. Growth Regul 4: 173–180, 1994
17. Delaney CA, Pavlovic D, Hoorens A, Pipeleers DG, Eizirik DL. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138: 2610–2614, 1997
18. Delaney CA, Tyrberg B, Bouwens L, Vaghef H, Hellman B, Eizirik DL. Sensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death. FEBS Lett 394: 300–306, 1996
19. Donath M, Shoelson S. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11: 98–107, 2011
20. Eizirik DL, Sandler S, Welsh N, Cetkovic-Cvrlje M, Nieman A, Geller DA, Pipeleers DG, Bendtzen K, Hellerstrom C. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 93: 1968–1974, 1994
21. Eizirik DL, Welsh M, Strandell E, Welsh N, Sandler S. Interleukin-1 beta depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism. Endocrinology 127: 2290–2297, 1990
22. Gazdar AF, Chick WL, Oie HK, Sims HL, King DL, Weir GC, Lauris V. Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc Natl Acad Sci USA 77: 3519–3523, 1980
23. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126: 131–138, 1982
24. Heitmeier MR, Corbett JA. Cytotoxic role of nitric oxide in diabetes. In: Nitric oxide biology and pathobiology, edited by Ignarro LJ. San Diego, CA: Academic, 2000, p. 785–810
25. Hill JR, Corbett JA, Baldwin AC, McDaniel ML. Nitric oxide production by the rat insulinoma cell line, RINm5F, is specific for IL-1: a spectrophotometric IL-1 bioassay. Anal Biochem 236: 14–19, 1996
26. Hughes KJ, Chambers KT, Meares GP, Corbett JA. Nitric oxides mediates a shift from early necrosis to late apoptosis in cytokine-treated beta-cells that is associated with irreversible DNA damage. Am J Physiol Endocrinol Metab 297: E1187–E1196, 2009
27. Hughes KJ, Meares GP, Chambers KT, Corbett JA. Repair of nitric oxide-damaged DNA in beta-cells requires JNK-dependent GADD45alpha expression. J Biol Chem 284: 27402–27408, 2009
28. Iwahashi H, Hanafusa T, Eguchi Y, Nakajima H, Miyagawa J, Itoh N, Tomita K, Namba M, Kuwajima M, Noguchi T, Tsujimoto Y, Matsuzawa Y. Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2. Diabetologia 39: 530–536, 1996
29. Johannesen J, Pociot F, Karlsen AE, Mandrup-Poulsen T, Nerup J. Strain-dependent difference in inducible nitric oxide synthesis (iNOS) expression in rat pancreatic islets correlates with interferon regulating factor 1 (IRF-1) and heat shock protein 70 (HSP70) expression. Eur Cytokine Netw 12: 501–509, 2001
30. Kelly CB, Blair LA, Corbett JA, Scarim AL. Isolation of islets of Langerhans from rodent pancreas. Methods Mol Med 83: 3–14, 2003
31. Khan P, Idrees D, Moxley MA, Corbett JA, Ahmad F, von Figura G, Sly WS, Waheed A, Hassan MI. Luminol-based chemiluminescent signals: clinical and non-clinical application and future uses. Appl Biochem Biotechnol 173: 333–355, 2014
32. Kim YM, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272: 31138–31148, 1997
33. Lacy PE. The intraislet macrophage and type I diabetes. Mt Sinai J Med 61: 170–174, 1994
34. Lei X, Zhang S, Bohrer A, Barbour SE, Ramanadham S. Role of calcium-independent phospholipase A(2)β in human pancreatic islet betacell apoptosis. Am J Physiol Endocrinol Metab 303: E1386–E1395, 2012
35. Li J, Billiar TR, Talanian RV, Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 240: 419–424, 1997
36. Lightfoot YL, Chen J, Mathews CE. Immune-mediated beta-cell death in type 1 diabetes: lessons from human beta-cell lines. Eur J Clin Invest 42: 1244–1251, 2012
37. Liu D, Pavlovic D, Chen MC, Flodstrom M, Sandler S, Eizirik DL. Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes 49: 1116–1122, 2000
38. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39: 1005–1029, 1996
39. Mandrup-Poulsen T, Bendtzen K, Nielsen JH, Bendixen G, Nerup J. Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 40: 424–429, 1985
40. Mathews CE, Leiter EH, Spirina O, Bykhovskaya Y, Gusdon AM, Ringquist S, Fischel-Ghodsian N. mt-Nd2 Allele of the ALR/Lt mouse confers resistance against both chemically induced and autoimmune diabetes. Diabetologia 48: 261–267, 2005
41. Mathews CE, Suarez-Pinzon WL, Baust JJ, Strynadka K, Leiter EH, Rabinovitch A. Mechanisms underlying resistance of pancreatic islets from ALR/Lt mice to cytokine-induced destruction. J Immunol 175: 1248–1256, 2005
42. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233: 119–125, 1993
43. Mohr S, Zech B, Lapetina EG, Brune B. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem Biophys Res Commun 238: 387–391, 1997
44. Newby BN, Terada N, Mathews CE. In search of a surrogate: engineering human beta cell lines for therapy. Trends Endocrinol Metab 25: 378–380, 2014
45. Nishiki Y, Adewola A, Hatanaka M, Templin AT, Maier B, Mirmira RG. Translational control of inducible nitric oxide synthase by p38 MAPK in islet beta-cells. Mol Endocrinol 27: 336–349, 2013
46. Padgett LE, Broniowska KA, Hansen PA, Corbett JA, Tse HM. The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann N Y Acad Sci 1281: 16–35, 2013
47. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, Schulz R, Lakey JR, Warnock GL, Rajotte RV. Human pancreatic islet beta-cell destruction by cytokines is independent of nitric oxide production. J Clin Endocrinol Metab 79: 1058–1062, 1994
48. Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 71: 152–156, 1990
49. Ravassard P, Hazhouz Y, Pechberty S, Bricout-Neveu E, Armanet M, Czernichow P, Scharfmann R. A genetically engineered human pancreatic beta cell line exhibiting glucose-inducible insulin secretion. J Clin Invest 121: 3589–3597, 2011
50. Repetto G, del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 3: 1125–1131, 2008
51. Rosales AL, Cunningham JM, Bone AJ, Green IC, Green MH. Repair of cytokine-induced DNA damage in cultured rat islets of Langerhans. Free Radic Res 38: 665–674, 2004
52. Rossig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mulsch A, Dimmeler S. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 274: 6823–6826, 1999
53. Sandler S, Andersson A, Hellerstrom C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 121: 1424–1431, 1987
54. Scarim AL, Heitmeier MR, Corbett JA. Heat shock inhibits cytokineinduced nitric oxide synthase expression by rat and human islets. Endocrinology 139: 5050–5057, 1998
55. Scarim AL, Heitmeier MR, Corbett JA. Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta. Endocrinology 138: 5301–5307, 1997
56. Southern C, Schulster D, Green IC. Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-argininedependent nitric oxide generating mechanism. FEBS Lett 276: 42–44, 1990
57. Steer SA, Scarim AL, Chambers KT, Corbett JA. Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med 3: e17, 2006
58. Stephens LA, Thomas HE, Kay TW. Protection of NIT-1 pancreatic beta-cells from immune attack by inhibition of NF-kappaB. J Autoimmun 10: 293–298, 1997
59. Urra H, Dufey E, Lisbona F, Rojas-Rivera D, Hetz C. When ER stress reaches a dead end. Biochim Biophys Acta 1833: 3507–3517, 2013
60. Weber SM, Chambers KT, Bensch KG, Scarim AL, Corbett JA. PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. Am J Physiol Endocrinol Metab 287: E1171–E1177, 2004
61. Weber SM, Scarim AL, Corbett JA. Inhibition of IFN-gamma-induced STAT1 activation by 15-deoxy-delta 12,14-prostaglandin J2. Am J Physiol Endocrinol Metab 284: E883–E891, 2003
62. Welsh N, Eizirik DL, Bendtzen K, Sandler S. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129: 3167–3173, 1991
63. Welsh N, Margulis B, Borg LA, Wiklund HJ, Saldeen J, Flodstrom M, Mello MA, Andersson A, Pipeleers DG, Hellerstrom C, Eizirik DL. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus. Mol Med 1: 806–820, 1995
64. Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, Parslow D, Armistead S, Lemire K, Orrell J, Teich J, Chomicz S, Ferrick DA. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292: C125–C136, 2007
65. Zhou YP, Teng D, Dralyuk F, Ostrega D, Roe MW, Philipson L, Polonsky KS. Apoptosis in insulin-secreting cells. Evidence for the role of intracellular Ca2+ stores and arachidonic acid metabolism. J Clin Invest 101: 1623–1632, 1998.